Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR Serious Games (no longer under consideration since Jul 16, 2026)

Date Submitted: Jan 18, 2026

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Gamified Real-Time Video Observed Therapy (GRVOTS) Mobile Application Usability Study

  • Siti Aishah Abas; 
  • Nurhuda Ismail; 
  • Yuslina Zakaria; 
  • Siti Munira Yasin; 
  • Khalid Ibrahim; 
  • Ismassabah Ismail; 
  • Nur Atikah Rochin Demong; 
  • Nur Atikah Rochin Demong; 
  • Nur Atikah Rochin Demong; 
  • Maslinawati Mohamad; 
  • Asmah Razali; 
  • Mas Ahmad Sherzkawi; 
  • Norliza Ahamd

ABSTRACT

Background:

Direct Observed Therapy Short-course (DOTS) has been used to ensure Tuberculosis (TB) drug compliance worldwide. However, due to its inconvenience, digitalizing this system into a virtual monitoring system via a mobile app can help deliver a more efficient tuberculosis management system. A gamified video-observed therapy system has been developed that connects three key users: the patient, supervisor, and administrator. This system enables drug monitoring and prevents patient loss to follow-up through an integrated patient tracking feature.

Objective:

Thus, the objective of our study is to assess the usability evaluation of the Gamified Real-Time Video Observed Therapy (GRVOTS) mobile apps, a mobile app specifically designed by having a combination of gamification elements in Video Direct Observed Therapy (VDOTS) to induce motivation from the perspective of the end user, both the patient and supervisor.

Methods:

11 supervisors with 54 patients participated in the 4-week usability study. GRVOTS mobile apps were installed, and patients were asked to complete tasks such as sending VOTS with supervisors to approve it daily. After one month, participants were asked to assess the usability of the app using the validated Malay version of the System Usability Scale Questionnaire (SUSQ). The one-sample t test was used to assess the usability score with a cutoff value of 68 for the usable mobile app. An independent t test was also performed to see if there is any difference between the usability marks of patients and supervisors.

Results:

The mean usability score was 74.73 (SD 14.64), which indicates that GRVOTS is a usable mobile app that can be used as a tool to replace physical DOTS. There are no significant differences between supervisors and patients (p<0.05).

Conclusions:

The GRVOTS mobile app can be used as a user-friendly tool for DOTS monitoring. A considerable amount of feedback and possibilities for improvement were also collected, which needs to be considered in future app development. There is potential for a commercially available app to be used in large-scale studies; thus, a single-arm intervention study is needed to measure the impact of the apps in the future. Clinical Trial: IRCT20230308057657NI, registered in March 2023


 Citation

Please cite as:

Abas SA, Ismail N, Zakaria Y, Yasin SM, Ibrahim K, Ismail I, Demong NAR, Demong NAR, Demong NAR, Mohamad M, Razali A, Sherzkawi MA, Ahamd N

Gamified Real-Time Video Observed Therapy (GRVOTS) Mobile Application Usability Study

JMIR Preprints. 18/01/2026:71972

DOI: 10.2196/preprints.71972

URL: https://preprints.jmir.org/preprint/71972

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.